Sports cardiology has emerged as a distinct subspecialty at the intersection of preventive cardiology and athlete care. While ...

“Losing my mum and brothers to the same heart condition makes the bench even more poignant. "But I know the best way to ...

Rocket Pharmaceuticals, Inc. ( RCKT) TD Cowen 46th Annual Health Care Conference March 2, 2026 11:10 AM EST ...

Researchers at the National University of Singapore (NUS) have identified a protein called tyrosine phosphatase 1B (PTP1B) as a potential "switch" that can modulate a type of cancer cell death known ...

Michael Exton, CEO, highlighted, "Lexicon is advancing 3 very strong novel late-stage programs in the therapeutic areas of cardiometabolic disease and chronic pain." He emphasized progress in ...

Researchers at the National University of Singapore (NUS) have identified a protein called tyrosine phosphatase 1B (PTP1B) as a potential "switch" that can modulate a type of cancer cell death known ...

When medications aren’t doing enough to manage your hypertrophic cardiomyopathy (HCM), surgical procedures can offer real relief. HCM is a genetic heart condition in which parts of the heart muscle ...

Abbott is teaming up with AtaCor Medical to develop a next-generation implantable cardioverter defibrillator (ICD) designed to treat dangerous cardiac arrhythmias without routing wires through the ...

Shared decision-making has emerged as a crucial element in the realm of sports cardiology, highlighting the importance of a collaborative partnership between the athletes and the clinician. The ...

Many symptoms of hypertrophic cardiomyopathy (HCM) are mild, particularly in the early stages of the disease, so they may be easy to dismiss. Symptoms such as shortness of breath during exercise, ...

Aficamten offers a new treatment option for symptomatic obstructive hypertrophic cardiomyopathy (oHCM). Clinical trials SEQUOIA-HCM and MAPLE-HCM showed aficamten's efficacy in improving exercise ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved aficamten to improve functional capacity and symptoms in adults with obstructive hypertrophic ...